Abstract:OBJECTIVE: The objective of this study was to evaluate whether blastocyst culture of human suboptimal embryos could help for embryo selection and improve clinical outcomes.DESIGN: Retrospective study.MATERIALS AND METHODS: The inclusion criteria were patients who had only suboptimal embryos (all embryos ≤6-cell or embryo fragments >10%) on Day 3. In Day 3 transfer group, embryos were selected and transferred on Day 3. In blastocyst culture group, embryos were cultured to Day 5 and transferred if reached blastocyst stage. Embryos were cultured in Vitrolife G5 series culture media at 37.5°C, 6% CO2, 5% O2. The mean age of patients was not significantly different between the groups (32.3 VS. 32.0 years). Clinical pregnancy, ongoing pregnancy and implantation rate were compared between the groups using χ Test.RESULTS: In Day 3 transfer group, 241 embryos of 114 patients (2.1 embryos /patient) were transferred, 59 were implanted (24.5%), clinical pregnancy was confirmed in 44 patients (38.6%), and ongoing pregnancy was defined in 40 patients (35.1%; miscarriage=1, ectopic pregnancy=3). In blastocyst culture group, 421 embryos of 106 patients were cultured to Day 5, 88 reached blastocyst (20.9%), and 18 blastocysts were scored ≥ 3BB (Gardener's grading criteria) (4.3%). Fifty-seven cycles (53.8%) were cancelled because of unavailability of blastocysts. Eighty-four blastocysts of 49 patients (1.7 embryos /patient) were transferred, 15 were implanted (17.9%), and clinical pregnancy and ongoing pregnancy was confirmed in 12 patients (11.3% per oocyte retrieval, 24.5% per embryo transfer). The mean number of transferred embryos (P=0.001), clinical pregnancy and ongoing pregnancy rate per oocyte retrieval (P<0.001) were significantly higher in Day 3 transfer group.CONCLUSIONS: Human embryos with suboptimal morphology showed limited developmental potential. Extended in vitro culture has more adverse stress on them, which can lead to developmental arrest. Blastocyst culture of suboptimal embryos does not improve clinical outcomes. OBJECTIVE: The objective of this study was to evaluate whether blastocyst culture of human suboptimal embryos could help for embryo selection and improve clinical outcomes. DESIGN: Retrospective study. MATERIALS AND METHODS: The inclusion criteria were patients who had only suboptimal embryos (all embryos ≤6-cell or embryo fragments >10%) on Day 3. In Day 3 transfer group, embryos were selected and transferred on Day 3. In blastocyst culture group, embryos were cultured to Day 5 and transferred if reached blastocyst stage. Embryos were cultured in Vitrolife G5 series culture media at 37.5°C, 6% CO2, 5% O2. The mean age of patients was not significantly different between the groups (32.3 VS. 32.0 years). Clinical pregnancy, ongoing pregnancy and implantation rate were compared between the groups using χ Test. RESULTS: In Day 3 transfer group, 241 embryos of 114 patients (2.1 embryos /patient) were transferred, 59 were implanted (24.5%), clinical pregnancy was confirmed in 44 patients (38.6%), and ongoing pregnancy was defined in 40 patients (35.1%; miscarriage=1, ectopic pregnancy=3). In blastocyst culture group, 421 embryos of 106 patients were cultured to Day 5, 88 reached blastocyst (20.9%), and 18 blastocysts were scored ≥ 3BB (Gardener's grading criteria) (4.3%). Fifty-seven cycles (53.8%) were cancelled because of unavailability of blastocysts. Eighty-four blastocysts of 49 patients (1.7 embryos /patient) were transferred, 15 were implanted (17.9%), and clinical pregnancy and ongoing pregnancy was confirmed in 12 patients (11.3% per oocyte retrieval, 24.5% per embryo transfer). The mean number of transferred embryos (P=0.001), clinical pregnancy and ongoing pregnancy rate per oocyte retrieval (P<0.001) were significantly higher in Day 3 transfer group. CONCLUSIONS: Human embryos with suboptimal morphology showed limited developmental potential. Extended in vitro culture has more adverse stress on them, which can lead to developmental arrest. Blastocyst culture of suboptimal embryos does not improve clinical outcomes.

The clinical outcomes of day 3 4-cell embryos after extended in vitro culture

Blastocyst Culture of Human Suboptimal Embryos Does Not Improve Clinical Outcomes

Association of the duration of post-thaw culture with clinical outcome after vitrified-warmed day 3 embryo transfer in 10,464 cycles: A retrospective cohort study.

Study on Culture of Human Embryo Blastocyst and Its Related Factors

Improving the clinical outcomes by extended culture of day 3 embryos with low blastomere number to blastocyst stage following frozen–thawed embryo transfer

Predictive Value of the Number of Frozen Blastocysts in Live Birth Rates of the Transferred Fresh Embryos

A Comparison of Implantation, Miscarriage and Pregnancy Rates of Single and Double Day 3 Embryo Transfer Between Fresh and Frozen Thawed Transfer Cycles: a Retrospective Study.

Slow Freezing Should Not Be Totally Substituted by Vitrification when Applied to Day 3 Embryo Cryopreservation: an Analysis of 5613 Frozen Cycles

Extended embryo culture in human assisted reproduction treatments

Developmental potential of different embryos on day 3: a retrospective study

The effect of Day 3 cell number on pregnancy outcomes in vitrified-thawed single blastocyst transfer cycles

Impacts of different culture times on pregnancy outcomes after thawing of cleavage stage embryos

Cell Number on Day 3 of Embryo Development is Associated with Ploidy and Pregnancy Rates

Does the cell number of 0PN embryos on day 3 affect pregnancy and neonatal outcomes following single blastocyst transfer?

The transfer of double cleavage embryos developed from two four‐cell embryos may not represent an optimal treatment strategy in cycles with a greater number of four‐cell embryos on Day 2

Clinical value of transferring blastocysts derived from 0PN/1PN or grade III embryos

Improved Developmental Competence and Spindle Assembly of in Vitro Maturation of Human Oocytes by Prolonged Culture Duration

The TLI system can help day-3 single cleavage embryo transfer to obtain comparative clinical outcomes to day-4 or day-5

Reconsidering Day 3 Embryo Quality in Planned Freeze-All Blastocyst Cycles

Optimizing single blastocyst selection: the role of day 3 embryo morphology in vitrified-warmed blastocyst transfer cycles

Clinical outcomes after elective double-embryo transfer in frozen cycles for women of advanced maternal age A retrospective cohort study